. 2017 Nov 28;7(1):115–123. doi: 10.1530/EC-17-0327
This work is licensed under a Figure 2.
Effect of liraglutide or placebo treatment on levels of MR-pro-adrenomedullin, copeptin, and MR-proANP. Median and interquartile range before and after 26 weeks of treatment.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.